While several drugs have been part of treatment protocols through the pandemic, no orally administered drug had got regulatory clearance in any country until molnupiravir. Read More
reported by Kaunain Sheriff M at The Indian Express
While several drugs have been part of treatment protocols through the pandemic, no orally administered drug had got regulatory clearance in any country until molnupiravir. Read More
reported by Kaunain Sheriff M at The Indian Express
Even if calendar year growth of 8.8 percent and 8.3 percent are considered, India would still be the fastest-growing economy. India?s adequacy of foreign exchange reserves should be the least of the worries for credit rating agencies. Read More
reported by at Moneycontrol
Complex processes, scattered production units, need for more safety zones and shortage of skilled staffers are some of the top reasons that restricted Bharat Biotech?s Covaxin from becoming the poster-boy of India?s vaccination story against Covid-19. Read More
reported by Himani Chandna at News18
US-based Adagio Therapeutics has allowed the company to manufacture and commericalise the ADG20-based treatment in India, as well as in select markets. | Latest News India Read More
reported by hindustantimes.com at Hindustan Times
India’s Economy 2021: The latest annual report of the Periodic Labour Force Survey (PLFS) has surprised everyone by claiming that the unemployment rate fell in a year when India’s GDP growth was at its weakest Read More
reported by Udit Misra at The Indian Express
Recent Comments